^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

PF-06753512

i
Other names: PF-06753512, PrCa VBIR, PF 6753512, PF-6753512 , VBIR-1
Associations
Trials
Company:
Pfizer
Drug class:
CTLA4 inhibitor, Immunostimulant, IL-2 stimulant
Related drugs:
Associations
Trials